Background
==========

Continuous veno-venous hemodiafiltration (CVVHDF) with regional citrate anticoagulation (RCA) has been applied to the treatment of critically ill acute renal failure (ARF) patients for years. It has a substantial effect on acid-base homeostasis. Accordingly, we investigated a cohort of patients requiring CVVHDF and assessed their acid-base changes by quantitative biophysical principles (Stewart-Figge approach).

Methods
=======

We studied 32 consecutive critical care ARF patients on CVVHDF with RCA. All relevant variables for acid-base analysis were measured according to the Stewart-Figge methodology.

Results
=======

Before CVVHDF treatment, the patients had metabolic acidosis with mild increase of the anion gap. The excess of unmeasured anions was the most important component of acidosis. Median lactate, phosphate and chloride levels were in the normal range. The median albumin was 2.3 mg/dl and had an alkalinizing effect.

On the third CVVHDF day, the median pH, bicarbonate, anion gap, BE and SIG had significantly decreased. The median value of the total calcium-ionic calcium ratio, a surrogate marker of citrate accumulation, did not change significantly over treatment, and was maintained below 2.5 mg/dl.

Conclusion
----------

In critically ill ARF patients, CVVHDF with RCA is a safe RRT modality and it corrected metabolic acidosis through its effects on unmeasured anions.

  -------- ------ ----------- ------ ----------- ------ ----------- ------ ----------- --------------
           Pre    25th/75th   D1     25th/75th   D2     25th/75th   D3     25th/75th   Friedman
  pH       7.35   7.25/7.41   7.37   7.33/7.4    7.42   7.38/7.45   7.42   7.38/7.46   *P*\< 0.0001
  pCO~2~   34.9   30.7/42.6   37.9   33.9/42.3   38.7   34.3/42.9   38     34.5/41.5   *P*= 0.3773
  HCO~3~   19.3   17.3/21     21.6   19.5/23.5   24.6   21.6/25.9   25.5   21.4/26.6   *P*\< 0.0001
  BE       -5.9   -8.7/-3.3   -2.9   -5.1/-1.3   0.2    -3.2/2.3    0.8    -2.6/2.6    *P*\< 0.001
  SIDa     40     36/43.6     39.1   36.2/40.8   39     36.6/40.5   39.2   36.5/41.8   *P*= 0.9189
  SIDe     29.1   26.4/30.7   31     28.2/33     33     31.2/34.6   33.6   32/36       *P*\< 0.0001
  SIG      10.4   7.2/14.5    7.21   5.8/10.8    5.5    3.7/7.2     5.1    4/7         *P*\< 0.001
  AG       17.6   15.7/22.8   16.6   14.5/18.5   13.8   11.7/16     14.1   13/15.7     *P*\< 0.0001
  A-       8.6    7.7/10.5    8.9    8.8/10.5    8.6    7.8/10.6    8.7    7.9/10.3    *P*= 0.7704
  -------- ------ ----------- ------ ----------- ------ ----------- ------ ----------- --------------
